For instance, single-cell RNA sequencing was leveraged to examine changes in specific immune cell subpopulations within the TME of EGFR-mutant NSCLC patients who developed resistance after treatment with EGFR-TKIs. This evidence concerns the gene EGFR and non-small cell lung carcinoma.